# Inositol to Reduce Retinopathy of Prematurity

> **NCT01954082** · PHASE3 · TERMINATED · sponsor: **NICHD Neonatal Research Network** · enrollment: 638 (actual)

## Conditions studied

- Retinopathy of Prematurity (ROP)

## Interventions

- **DRUG:** myo-Inositol 5% Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01954082
- **Lead sponsor:** NICHD Neonatal Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04-17
- **Primary completion:** 2016-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 638 (ACTUAL)
- **Why stopped:** Study terminated due to safety concerns; participant follow up will continue until March 2018
- **Last updated:** 2019-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01954082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01954082, "Inositol to Reduce Retinopathy of Prematurity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01954082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*